spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  FAME Trial 

 HSMN NewsFeed - 10 Oct 2016
St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 18 May 2016
St. Jude Medical Announces European Launch of the Latest in PressureWire Guidewire Technology to Measure Pressure Differences Across Narrowed Coronary Arteries
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 16 May 2013
St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 11 Mar 2013
St. Jude Medical Announces Launch of 3-D Vessel Reconstruction Technology in Japan
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jan 2012
Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis
Devices Cardiology
 HSMN NewsFeed - 20 May 2011
Cost Effectiveness Study Determines FFR Can Improve Health while Reducing Economic Burden in UK, France and Italy
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Apr 2011
St. Jude Medical Sponsored Study Determines FFR Can Improve Health while Reducing Economic Burden to German Healthcare System
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Dec 2010
Economic Evaluation of FAME Trial Confirms Using FFR in Treatment of Coronary Artery Disease Is Cost-Effective
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Aug 2010
New 2010 ESC Guidelines for Percutaneous Coronary Interventions Reinforce Importance of FFR in Treatment of Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in Patients With Stable Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2010
Volcano Announces 510(k) Clearance, CE Mark Approval, and First Clinical Use for the PrimeWire PRESTIGE(TM) Pressure Guide Wire
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Mar 2010
St. Jude Medical Announces Multiple Enhancements to Industry-Leading PressureWire FFR Measurement System
Devices Monitoring Cardiology
 HSMN NewsFeed - 12 Mar 2010
Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems
Devices Interventional Monitoring
 HSMN NewsFeed - 22 Dec 2009
Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Dec 2009
Importance of FFR in Treatment of Coronary Artery Disease Confirmed by New PCI Guidelines
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
FAME Trial Two-Year Follow-Up Results Demonstrate Continued Reduction in Risk of Death or Heart Attack When Physicians Use St. Jude Medical Fractional Flow Reserve Technology Prior to Implanting Coronary Stents
Devices Interventional Cardiology
Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!